Article
Study on the mechanism of action of probucol in the treatment of coronary artery disease based on network pharmacology and molecular docking technology
2023-11-07
Abstract excerpt
<h4>Objective: </h4> The latest studies have shown that the combined use of aggressive lipid-lowering and inflammation-reducing therapies might reduce atherosclerotic risk. Probucol has hypolipidemic, antioxidative, and anti-inflammatory effects. Through network pharmacology and molecular docking, the core genes, biological function, and signalling pathways of Probucol in coronary artery disease/coronary heart dis...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c368c2fa-c402-5ab0-88cb-32af73706d11
- DOI
- 10.21203/rs.3.rs-3543201/v1
